Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 22483044)

1.

The pathophysiology of fragile X (and what it teaches us about synapses).

Bhakar AL, Dölen G, Bear MF.

Annu Rev Neurosci. 2012;35:417-43. doi: 10.1146/annurev-neuro-060909-153138. Epub 2012 Apr 5. Review.

2.

The state of synapses in fragile X syndrome.

Pfeiffer BE, Huber KM.

Neuroscientist. 2009 Oct;15(5):549-67. doi: 10.1177/1073858409333075. Epub 2009 Mar 26. Review.

3.

Altered synaptic plasticity in a mouse model of fragile X mental retardation.

Huber KM, Gallagher SM, Warren ST, Bear MF.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50.

4.

Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Bassell GJ, Warren ST.

Neuron. 2008 Oct 23;60(2):201-14. doi: 10.1016/j.neuron.2008.10.004. Review.

5.

Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.

Ronesi JA, Huber KM.

Sci Signal. 2008 Feb 5;1(5):pe6. doi: 10.1126/stke.15pe6. Review.

PMID:
18272470
6.

Dysregulation of mTOR signaling in fragile X syndrome.

Sharma A, Hoeffer CA, Takayasu Y, Miyawaki T, McBride SM, Klann E, Zukin RS.

J Neurosci. 2010 Jan 13;30(2):694-702. doi: 10.1523/JNEUROSCI.3696-09.2010.

7.
8.

Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice.

Iliff AJ, Renoux AJ, Krans A, Usdin K, Sutton MA, Todd PK.

Hum Mol Genet. 2013 Mar 15;22(6):1180-92. doi: 10.1093/hmg/dds525. Epub 2012 Dec 18.

9.

The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain.

Aschrafi A, Cunningham BA, Edelman GM, Vanderklish PW.

Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):2180-5. Epub 2005 Jan 31.

10.

Fragile X protein FMRP is required for homeostatic plasticity and regulation of synaptic strength by retinoic acid.

Soden ME, Chen L.

J Neurosci. 2010 Dec 15;30(50):16910-21. doi: 10.1523/JNEUROSCI.3660-10.2010.

11.
12.

Fragile X mental retardation protein in plasticity and disease.

Todd PK, Malter JS.

J Neurosci Res. 2002 Dec 1;70(5):623-30. Review.

PMID:
12424729
13.

Fragile X syndrome: From protein function to therapy.

Bagni C, Oostra BA.

Am J Med Genet A. 2013 Nov;161A(11):2809-21. doi: 10.1002/ajmg.a.36241. Epub 2013 Sep 24. Review.

PMID:
24115651
14.

Fragile X: translation in action.

Bear MF, Dölen G, Osterweil E, Nagarajan N.

Neuropsychopharmacology. 2008 Jan;33(1):84-7. Epub 2007 Oct 17. Review.

16.
17.

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.

Gross C, Nakamoto M, Yao X, Chan CB, Yim SY, Ye K, Warren ST, Bassell GJ.

J Neurosci. 2010 Aug 11;30(32):10624-38. doi: 10.1523/JNEUROSCI.0402-10.2010.

18.

Sunrise at the synapse: the FMRP mRNP shaping the synaptic interface.

Antar LN, Bassell GJ.

Neuron. 2003 Feb 20;37(4):555-8. Review.

PMID:
12597853
19.

Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.

Ronesi JA, Collins KA, Hays SA, Tsai NP, Guo W, Birnbaum SG, Hu JH, Worley PF, Gibson JR, Huber KM.

Nat Neurosci. 2012 Jan 22;15(3):431-40, S1. doi: 10.1038/nn.3033.

20.

Fragile X mental retardation protein regulates protein expression and mRNA translation of the potassium channel Kv4.2.

Gross C, Yao X, Pong DL, Jeromin A, Bassell GJ.

J Neurosci. 2011 Apr 13;31(15):5693-8. doi: 10.1523/JNEUROSCI.6661-10.2011.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk